In addition, YOD1-mediated coagulation in MRSA-induced sepsis was blocked by the administration of MCC950, a highly potent and specific inhibitor of NLRP3, which supported that YOD1-regulated NLRP3 inflammasome-dependent coagulation in the process of MRSA-induced DIC. Here, NLRP3 is linked to Sepsis.